Navigation Links
Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Date:8/28/2007

Completion of Adult Trial Enrollment follows FDA approval of Zingo in

Children

SOUTH SAN FRANCISCO, Calif., Aug. 28 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that it has completed enrollment of the Phase 3 clinical study of Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system to reduce pain associated with peripheral venous access procedures in adults. Zingo, a fast-acting topical, needle-free system for local analgesia, was approved by the U.S. Food and Drug Administration (FDA) on August 16, 2007 to reduce the pain associated with venous access procedures, such as IV insertions or blood draws, in children ages three to 18. Anesiva expects to announce results from the adult trial in October.

"Our goal is to utilize the data from this Phase 3 study to file a supplemental new drug application for the use of Zingo in adults," said John P. McLaughlin, chief executive officer of Anesiva. "In addition, we look forward to providing more detail on the commercialization of Zingo in the approved indication for children in the coming weeks."

Venous access procedures, such as IV insertions and blood draws, are among the most common interventions performed in hospitals, with more than 400 million such procedures performed each year in U.S. hospitals.

The Phase 3 study of Zingo in adults enrolled 699 patients undergoing intravenous cannulation or venipuncture procedures at multiple clinical centers in the U.S. Patients were randomized to receive treatment with either Zingo or placebo approximately one to three minutes prior to the peripheral venous access procedure.

About Zingo

Zingo is a ready-to-use
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
3. Celsion Completes Enrollment in Phase I Liver Cancer Study
4. LANI completes Phase I in Japan and to commence Phase I in UK
5. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
8. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... SAINT PAUL, Minn. , May 23, 2013 /PRNewswire/ ... Angeion Corporation), a global medical technology company, today scheduled ... the second quarter of fiscal year 2013, ended April ... ET on Thursday, May 30, 2013. The Company will ... year 2013 after the markets close on Thursday, May ...
(Date:5/23/2013)... , May 23, 2013  Hadasit Bio-Holdings Ltd. ... of biotech companies, based on intellectual property developed ... Israel ,s foremost medical research center, today ... Ltd., received significant funding from the Israeli Ministry ... Scientist (OCS) to support product development and advance ...
(Date:5/23/2013)... SANTA MONICA, Calif. , May 23, 2013 /PRNewswire-USNewswire/ ... of a program that would have required them to ... announced today by Consumer Watchdog and Whatley Kallas LLC.  ... San Diego Superior Court, alleged that Blue Cross,s mandatory ... HIV/AIDS patients, threatening their health and privacy. ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
... March 16 SpineMark CRO Management, a wholly-owned ... recently signed an agreement with Ranier Technology, a ... provide contract research support services for the Ranier CAdisc™-L ... device for treatment of degenerative disc disease in the ...
... ) today announced that the company will hold its annual meeting of stockholders on Wednesday, June 9, 2010 at 9:00a.m. Pacific Time ... . , ... , , ... ...
Cached Medicine Technology:San Diego Based CRO Signs Agreement With UK Based Spinal Device Manufacturer 2San Diego Based CRO Signs Agreement With UK Based Spinal Device Manufacturer 3PDL BioPharma To Hold Annual Meeting of Stockholders on June 9, 2010 2
(Date:5/25/2013)... 25, 2013 The Slim Weight Patch has ... results. This is due to the highly sought after ingredients ... weight patch offers an extra 2 months supply & premium ... and get the body you desire faster than ever. , ... , With Slim weight patch consumers can observe instant ...
(Date:5/25/2013)... 2013 For college students, few ... Increasingly, they are turning to prescription stimulants like ... For more on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm ... warns that students who pick up Adderall, “just ... for developing a physical and psychological dependency. While ...
(Date:5/25/2013)... 25, 2013 Superior Magnetics for Pain ... in seconds for arthritis, tendinitis and bursitis , Pain ... relief products announced a magnetic bracelet so ... for pain relief is demonstrated at fairs and festivals. ... Gauss magnets and has customers often report pain relief ...
(Date:5/25/2013)... 25, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html , ... judge's overturning of a jury's award of $6.5 million ... trial* in the country over allegations that the diabetes ... files. , The judge in the case ruled that ... his cancer was caused by the medication.** , Bloomberg ...
(Date:5/24/2013)... FL (PRWEB) May 25, 2013 The ... Cellulite Whisperer ® products from Sublime Beauty®. The ... to diminish cellulite, and many of the ingredients are ... deal with and is dreaded by many women," says ... concentrated holistic plan, women can diminish their cellulite." The ...
Breaking Medicine News(10 mins):Health News:Slim Weight Patch Advanced Weight Loss System Offers Extra Two Month Supply and Membership for Maximum Weight Loss 2Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Magnetic bracelet relieves pain in seconds announces Superior Magnetics 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4Health News:"Get Ready for Summer Sale" at Sublime Beauty® Continues: New Cellulite Whisperer® Products 2
... Aug. 19 (HealthDay News) -- At 3 years of age, Pablo ... He also had frequent severe constipation, so much so that he ... of Alexandria, Va. Because of the prolapse, a condition in ... doctors worried that the boy, who is now 13, had cystic ...
... delicti is a plain flacon from among the possessions of ... exhibit in the permanent collection of the Egyptian Museum of ... the vessel may have held a deadly secret. This is ... Helmut Wiedenfeld from the university,s Pharmacology Institute just discovered. After ...
... (August 19, 2011) Antibiotics can help ward off serious ... catheters for their dialysis treatments. But if antibiotics are used ... to the drugs. A new randomized controlled clinical trial ... used to treat other serious infections may be a safe ...
... News) -- Cases of Legionnaire,s disease in the United States ... report shows. And while Legionnaires, disease is serious and ... for concern, most people recover with antibiotic treatment, officials said. ... Centers for Disease Control and Prevention rose from 1,110 in ...
... 18 (HealthDay News) -- Two gene variations that increase smokers, ... Smokers with the variants also tend to smoke more and ... Researchers at the Centre for Addiction and Mental Health in ... cancer and 443 current or former smokers without cancer. ...
... Society congratulates Dietrich Manzey, Maria Luz, Stefan Mueller, ... receiving the 2011 Human Factors Prize for their ... Assistance on Performance, Waorkload, Situation Awareness, and Acquisition ... is health-care ergonomics, broadly defined to include research ...
Cached Medicine News:Health News:Gluten-Free Set This Boy Free 2Health News:Deadly medication? 2Health News:Deadly medication? 3Health News:Acne-treating antibiotic cuts catheter infections in dialysis patients 2Health News:Cases of Legionnaire's Disease Tripled in 10 Years 2Health News:Gene Variants That Boost Lung Cancer Risk Identified 2Health News:Paper on automation in surgery wins 2011 Human Factors Prize for Excellence in HF/E Research 2Health News:Paper on automation in surgery wins 2011 Human Factors Prize for Excellence in HF/E Research 3Health News:Paper on automation in surgery wins 2011 Human Factors Prize for Excellence in HF/E Research 4
A One Piece Support Garment - any length or size...
Body Suit w/Bra torso, Front Closure...
Gynecomastia Vest...
Ideal for breast compression and contouring breast cups....
Medicine Products: